CHICAGO--(BUSINESS WIRE)--NeuroTherapeutics Pharma, Inc., or NTP, a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, today announced the appointment of Corey S. Goodman, Ph.D., to its Board of Directors.
